J M Herrera, W A Alvarez, J P Freinhar, W B Lawson, J J Sramek
{"title":"辅助氯硝西泮治疗慢性精神分裂症。","authors":"J M Herrera, W A Alvarez, J P Freinhar, W B Lawson, J J Sramek","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Clonazepam was added to the neuroleptic regimen of 3 treatment-resistant schizophrenic patients with schizoaffective features. Manic symptoms improved but returned following discontinuation of clonazepam. The drug appears to benefit positive psychotic symptoms but worsens negative symptoms.</p>","PeriodicalId":77182,"journal":{"name":"International journal of psychosomatics : official publication of the International Psychosomatics Institute","volume":"38 1-4","pages":"17-20"},"PeriodicalIF":0.0000,"publicationDate":"1991-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Adjunctive clonazepam in the treatment of chronic schizophrenia.\",\"authors\":\"J M Herrera, W A Alvarez, J P Freinhar, W B Lawson, J J Sramek\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Clonazepam was added to the neuroleptic regimen of 3 treatment-resistant schizophrenic patients with schizoaffective features. Manic symptoms improved but returned following discontinuation of clonazepam. The drug appears to benefit positive psychotic symptoms but worsens negative symptoms.</p>\",\"PeriodicalId\":77182,\"journal\":{\"name\":\"International journal of psychosomatics : official publication of the International Psychosomatics Institute\",\"volume\":\"38 1-4\",\"pages\":\"17-20\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1991-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of psychosomatics : official publication of the International Psychosomatics Institute\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of psychosomatics : official publication of the International Psychosomatics Institute","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Adjunctive clonazepam in the treatment of chronic schizophrenia.
Clonazepam was added to the neuroleptic regimen of 3 treatment-resistant schizophrenic patients with schizoaffective features. Manic symptoms improved but returned following discontinuation of clonazepam. The drug appears to benefit positive psychotic symptoms but worsens negative symptoms.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
